Report for Cheng JD

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (7)

Title : Extended structure-activity relationship and pharmacokinetic investigation of (4-quinolinoyl)glycyl-2-cyanopyrrolidine inhibitors of fibroblast activation protein (FAP) - Jansen_2014_J.Med.Chem_57_3053
Author(s) : Jansen K , Heirbaut L , Verkerk R , Cheng JD , Joossens J , Cos P , Maes L , Lambeir AM , De Meester I , Augustyns K , Van der Veken P
Ref : Journal of Medicinal Chemistry , 57 :3053 , 2014
Abstract : Jansen_2014_J.Med.Chem_57_3053
ESTHER : Jansen_2014_J.Med.Chem_57_3053
PubMedSearch : Jansen_2014_J.Med.Chem_57_3053
PubMedID: 24617858

Title : Selective Inhibitors of Fibroblast Activation Protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine Scaffold - Jansen_2013_ACS.Med.Chem.Lett_4_491
Author(s) : Jansen K , Heirbaut L , Cheng JD , Joossens J , Ryabtsova O , Cos P , Maes L , Lambeir AM , De Meester I , Augustyns K , Van der Veken P
Ref : ACS Med Chem Lett , 4 :491 , 2013
Abstract : Jansen_2013_ACS.Med.Chem.Lett_4_491
ESTHER : Jansen_2013_ACS.Med.Chem.Lett_4_491
PubMedSearch : Jansen_2013_ACS.Med.Chem.Lett_4_491
PubMedID: 24900696

Title : P2-substituted N-acylprolylpyrrolidine inhibitors of prolyl oligopeptidase: biochemical evaluation, binding mode determination, and assessment in a cellular model of synucleinopathy - Van der Veken_2012_J.Med.Chem_55_9856
Author(s) : Van der Veken P , Fulop V , Rea D , Gerard M , Van Elzen R , Joossens J , Cheng JD , Baekelandt V , De Meester I , Lambeir AM , Augustyns K
Ref : Journal of Medicinal Chemistry , 55 :9856 , 2012
Abstract : Van der Veken_2012_J.Med.Chem_55_9856
ESTHER : Van der Veken_2012_J.Med.Chem_55_9856
PubMedSearch : Van der Veken_2012_J.Med.Chem_55_9856
PubMedID: 23121075
Gene_locus related to this paper: pig-ppce

Title : Acylated Gly-(2-cyano)pyrrolidines as inhibitors of fibroblast activation protein (FAP) and the issue of FAP\/prolyl oligopeptidase (PREP)-selectivity - Ryabtsova_2012_Bioorg.Med.Chem.Lett_22_3412
Author(s) : Ryabtsova O , Jansen K , Van Goethem S , Joossens J , Cheng JD , Lambeir AM , De Meester I , Augustyns K , Van der Veken P
Ref : Bioorganic & Medicinal Chemistry Lett , 22 :3412 , 2012
Abstract : Ryabtsova_2012_Bioorg.Med.Chem.Lett_22_3412
ESTHER : Ryabtsova_2012_Bioorg.Med.Chem.Lett_22_3412
PubMedSearch : Ryabtsova_2012_Bioorg.Med.Chem.Lett_22_3412
PubMedID: 22525314

Title : Dipeptidyl peptidase 8\/9-like activity in human leukocytes - Maes_2007_J.Leukoc.Biol_81_1252
Author(s) : Maes MB , Dubois V , Brandt I , Lambeir AM , Van der Veken P , Augustyns K , Cheng JD , Chen X , Scharpe S , De Meester I
Ref : J Leukoc Biol , 81 :1252 , 2007
Abstract : Maes_2007_J.Leukoc.Biol_81_1252
ESTHER : Maes_2007_J.Leukoc.Biol_81_1252
PubMedSearch : Maes_2007_J.Leukoc.Biol_81_1252
PubMedID: 17287297

Title : Selective fluorescence probes for dipeptidyl peptidase activity-fibroblast activation protein and dipeptidyl peptidase IV - Lai_2007_Bioconjug.Chem_18_1246
Author(s) : Lai KS , Ho NH , Cheng JD , Tung CH
Ref : Bioconjug Chem , 18 :1246 , 2007
Abstract : Lai_2007_Bioconjug.Chem_18_1246
ESTHER : Lai_2007_Bioconjug.Chem_18_1246
PubMedSearch : Lai_2007_Bioconjug.Chem_18_1246
PubMedID: 17489551

Title : Phase II trial of single agent Val-boroPro (Talabostat) inhibiting Fibroblast Activation Protein in patients with metastatic colorectal cancer - Narra_2007_Cancer.Biol.Ther_6_1691
Author(s) : Narra K , Mullins SR , Lee HO , Strzemkowski-Brun B , Magalong K , Christiansen VJ , McKee PA , Egleston B , Cohen SJ , Weiner LM , Meropol NJ , Cheng JD
Ref : Cancer Biol Ther , 6 :1691 , 2007
Abstract : Narra_2007_Cancer.Biol.Ther_6_1691
ESTHER : Narra_2007_Cancer.Biol.Ther_6_1691
PubMedSearch : Narra_2007_Cancer.Biol.Ther_6_1691
PubMedID: 18032930